Janux Therapeutics, Inc. (JANX) has 2 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 31, 2026.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free